Sepiapterin reductase promotes hepatocellular carcinoma progression via FoxO3a/Bim signaling in a nonenzymatic manner

[1]  A. Hale,et al.  Nitric Oxide Modulates Metabolic Remodeling in Inflammatory Macrophages through TCA Cycle Regulation and Itaconate Accumulation , 2019, Cell reports.

[2]  Ya-ping Tang,et al.  A novel GTPCH deficiency mouse model exhibiting tetrahydrobiopterin-related metabolic disturbance and infancy-onset motor impairments. , 2019, Metabolism: clinical and experimental.

[3]  Eugene E. Kwan,et al.  CRISPR-suppressor scanning reveals a nonenzymatic role of LSD1 in AML , 2019, Nature Chemical Biology.

[4]  D. Geerts,et al.  Anti‐tumor effect of sulfasalazine in neuroblastoma , 2019, Biochemical pharmacology.

[5]  E. McNeill,et al.  The metabolite BH4 controls T cell proliferation in autoimmunity and cancer , 2018, Nature.

[6]  R. Deberardinis,et al.  Inosine Monophosphate Dehydrogenase Dependence in a Subset of Small Cell Lung Cancers. , 2018, Cell metabolism.

[7]  LaKesla R Iles,et al.  Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability , 2018, Clinical Cancer Research.

[8]  Yaoyong Li,et al.  Enhancer Activation by Pharmacologic Displacement of LSD1 from GFI1 Induces Differentiation in Acute Myeloid Leukemia , 2018, Cell reports.

[9]  K. Takayama,et al.  TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer , 2018, Oncogene.

[10]  B. Singh,et al.  BH3-only protein BIM: An emerging target in chemotherapy. , 2017, European journal of cell biology.

[11]  N. Perrimon,et al.  mTORC1 Couples Nucleotide Synthesis to Nucleotide Demand Resulting in a Targetable Metabolic Vulnerability. , 2017, Cancer cell.

[12]  Min Huang,et al.  Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity , 2017, Oncogene.

[13]  Jun-jie Yu,et al.  DT-13 synergistically enhanced vinorelbine-mediated mitotic arrest through inhibition of FOXM1-BICD2 axis in non-small-cell lung cancer cells , 2017, Cell Death and Disease.

[14]  X. Hou,et al.  DT-13 inhibits cancer cell migration by regulating NMIIA indirectly in the tumor microenvironment. , 2016, Oncology reports.

[15]  D. Geerts,et al.  Effect of sulfasalazine on human neuroblastoma: analysis of sepiapterin reductase (SPR) as a new therapeutic target , 2015, BMC Cancer.

[16]  K. Channon,et al.  Reduction of Neuropathic and Inflammatory Pain through Inhibition of the Tetrahydrobiopterin Pathway , 2015, Neuron.

[17]  D. Laskin,et al.  Sulfa Drugs Inhibit Sepiapterin Reduction and Chemical Redox Cycling by Sepiapterin Reductase , 2015, The Journal of Pharmacology and Experimental Therapeutics.

[18]  Junbo Hu,et al.  Threonine 32 (Thr32) of FoxO3 is critical for TGF-β-induced apoptosis via Bim in hepatocarcinoma cells , 2014, Protein & Cell.

[19]  D. Geerts,et al.  Novel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferation. , 2014, Journal of molecular biology.

[20]  K. Johnsson,et al.  Tetrahydrobiopterin Biosynthesis as an Off-Target of Sulfa Drugs , 2013, Science.

[21]  D. Laskin,et al.  Sepiapterin Reductase Mediates Chemical Redox Cycling in Lung Epithelial Cells* , 2013, The Journal of Biological Chemistry.

[22]  E. Werner,et al.  Alkylglycerol Monooxygenase , 2013, IUBMB life.

[23]  P. Galle,et al.  Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells , 2012, British Journal of Cancer.

[24]  N. Blau,et al.  An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia , 2012, Journal of Inherited Metabolic Disease.

[25]  P. Ward,et al.  Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.

[26]  K. Aldape,et al.  Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation , 2011, Nature.

[27]  Myoung-Dong Kim,et al.  Sepiapterin inhibits cell proliferation and migration of ovarian cancer cells via down-regulation of p70S6K-dependent VEGFR-2 expression. , 2011, Oncology reports.

[28]  E. Werner,et al.  Tetrahydrobiopterin: biochemistry and pathophysiology. , 2011, The Biochemical journal.

[29]  K. Johnsson,et al.  A yeast-based screen reveals that sulfasalazine inhibits tetrahydrobiopterin biosynthesis. , 2011, Nature chemical biology.

[30]  D. Kerr,et al.  Roles of tetrahydrobiopterin in promoting tumor angiogenesis. , 2010, The American journal of pathology.

[31]  F. Tarazi,et al.  Alterations in dopamine and glutamate neurotransmission in tetrahydrobiopterin deficient spr-/- mice: relevance to schizophrenia. , 2010, BMB reports.

[32]  P. Choong,et al.  Bim-targeted cancer therapy: A link between drug action and underlying molecular changes , 2009, Molecular Cancer Therapeutics.

[33]  G. Wildey,et al.  Runx1 Is a Co-activator with FOXO3 to Mediate Transforming Growth Factor β (TGFβ)-induced Bim Transcription in Hepatic Cells* , 2009, The Journal of Biological Chemistry.

[34]  Nenad Blau,et al.  Mutations in the BH4‐metabolizing genes GTP cyclohydrolase I, 6‐pyruvoyl‐tetrahydropterin synthase, sepiapterin reductase, carbinolamine‐4a‐dehydratase, and dihydropteridine reductase , 2006, Human mutation.

[35]  N. Blau,et al.  Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency. , 2001, Molecular genetics and metabolism.

[36]  M. Edelstein,et al.  New inhibitors of sepiapterin reductase. Lack of an effect of intracellular tetrahydrobiopterin depletion upon in vitro proliferation of two human cell lines. , 1992, The Journal of biological chemistry.

[37]  R. Deberardinis,et al.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.